Share-Based Compensation	6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	9. Share-Based Compensation The Company accounts for share-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation,” which requires the Company to recognize compensation expense for share-based awards, measured at the fair value of the awards at the grant date. The Company recognized $0.9 million of share-based compensation related expense during the three-month periods ended June 30, 2022 and 2021, respectively, and $1.8 million and $1.6 million during the six-month periods ended June 30, 2022 and 2021, respectively. The Company granted approximately 104,000 and 460,000 restricted stock units during the three-month periods ended June 30, 2022 and 2021, respectively, and approximately 688,000 and 460,000 restricted stock units during the six-month periods ended June 30, 2022 and 2021, respectively. There were zero and 2,000 options exercised during the six-months ended June 30, 2022 and 2021, respectively. The Company received zero and $13,000 in cash from employees and a non-employee director exercising options during the six-months ended June 30, 2021. The intrinsic value of options exercised during the six-months ended June 30, 2022 and 2021 was zero and $3,000, respectively.

Share-Based Compensation

6 Months Ended

Jun. 30, 2022

Share-based Payment Arrangement [Abstract]

9. Share-Based Compensation

The Company accounts for share-based compensation in accordance with Accounting Standards Codification (“ASC”) Topic 718, “Compensation – Stock Compensation,” which requires the Company to recognize compensation expense for share-based awards, measured at the fair value of the awards at the grant date. The Company recognized $0.9 million of share-based compensation related expense during the three-month periods ended June 30, 2022 and 2021, respectively, and $1.8 million and $1.6 million during the six-month periods ended June 30, 2022 and 2021, respectively.

The Company granted approximately 104,000 and 460,000 restricted stock units during the three-month periods ended June 30, 2022 and 2021, respectively, and approximately 688,000 and 460,000 restricted stock units during the six-month periods ended June 30, 2022 and 2021, respectively.

There were zero and 2,000 options exercised during the six-months ended June 30, 2022 and 2021, respectively. The Company received zero and $13,000 in cash from employees and a non-employee director exercising options during the six-months ended June 30, 2021. The intrinsic value of options exercised during the six-months ended June 30, 2022 and 2021 was zero and $3,000, respectively.